Notice to the media - COVID-19 Update (March 12, 2021) - The Prime Minister, Ministers and Government of Canada officials to hold a news conference on coronavirus disease
OTTAWA, ON, March 12, 2021 /CNW/ - The Prime Minister, Ministers and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19).
Date March 12, 2021
Time 11:30 AM (EST)
Location
Sir John A Macdonald Building, Room 200 144 Wellington Street, Ottawa, Ontario
The media availability will also be held by teleconference.
Toll-free (Canada/US) dial-in number: 1-866-206-0153 Local dial-in number: 613-954-9003
Passcode: 6822783#
NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.
Phoenix Motor Inc. , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced it has surpassed 55 million miles driven across its range of products.Phoenix offers a range of...
Phoenix Motor Inc. , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced the appointment of Michael Yung as its new Chief Financial Officer (CFO), effective April 17,...
Centamin plc ("Centamin", "Group" or "the Company") (LSE:CEY)QUARTERLY REPORTfor the three months ended 31 March 2024MARTIN HORGAN, CEO, commented: "The scheduled processing of lower-grade ore from the open pit,...
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announces the formation of a new...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...
